Anthera Pharmaceuticals (OTCMKTS:ANTH) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH)’s stock price passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares traded.

Anthera Pharmaceuticals Price Performance

Anthera Pharmaceuticals Company Profile

Anthera Pharmaceuticals was a U.S.-based biopharmaceutical company focused on developing therapies for serious inflammatory, autoimmune and gastrointestinal diseases. The company operated primarily as a clinical-stage drug developer and did not establish a broad commercial product portfolio.

Its principal programs included varespladib, an investigational treatment intended to address inflammatory conditions, and Sollpura (liprotamase), an oral pancreatic enzyme replacement therapy for people with exocrine pancreatic insufficiency.